Medication info
Acyco Tablet 200 mg (Acyclovir)

Acyco Tablet 200 mg (Acyclovir)

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Light blue, round tablet
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 200404701 · Notified 2004.07.09 · Insurance code 671700720

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes); treatment of herpes zoster and varicella
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose, 5 times daily at 4-hour intervals, for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically interrupt treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or impaired gastrointestinal absorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; therefore, caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are not yet sufficient data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes); treatment of herpes zoster and varicella

  • Primary genital herpes
  • recurrent genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • herpes zoster virus infections
  • acute pain
  • chickenpox
View approved original text

This medication is used for the treatment and prevention of herpes simplex virus infections of the skin and mucous membranes, including initial and recurrent genital herpes. It is also particularly effective in relieving acute pain associated with herpes zoster virus infections. However, the efficacy for postherpetic neuralgia has not yet been confirmed. It is also used for the treatment of chickenpox in children over 2 years old and helps alleviate symptoms caused by infection and promote recovery. In general, this drug is effectively used for herpes simplex, herpes zoster, and chickenpox.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose, 5 times daily at 4-hour intervals, for 5 days. In cases of severe initial infection, treatment may be extended. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) It is best to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To determine the natural course of the disease, patients receiving long-term treatment should periodically interrupt treatment every 6 ~ 12 months for assessment. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunodeficiency (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per dose or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunodeficiency or impaired gastrointestinal absorption. 3) It is best to start treatment as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience neuropsychiatric adverse reactions; therefore, caution should be exercised, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount accumulated following intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per dose twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per dose 3 times daily at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Same as the adult dose. 2) Under 2 years of age: Administer 1/2 of the adult dose. 3) There are not yet sufficient data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children aged 2 years and older: Administer 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours after the rash appears.

Precautions

This medication should not be used in individuals with a known allergy to this drug or its components. Patients with impaired kidney function may experience mental and neurological side effects easily while using this medication, so caution is required. Patients with liver function issues may see a worsening of liver function from taking this medication; therefore, careful administration is necessary. Children and the elderly need to use this medication with special caution, and if necessary, it should be administered in the minimum effective dose. While taking this medication, it is possible for severe allergic reactions, such as shock, to occur rarely; if symptoms like low blood pressure or breathing difficulties occur, use should be stopped immediately and medical attention sought. There can be skin reactions such as rashes or hives; in severe cases, serious skin reactions like Stevens-Johnson syndrome can occur, so if any unusual symptoms arise, discontinue use and consult a physician. Mental confusion, drowsiness, seizures, and hallucinations may occur, particularly in the elderly or patients with reduced kidney function, where they may occur more frequently. There can be stress on the kidneys, so regular monitoring is necessary for patients with impaired kidney function. Blood tests may show changes in white blood cell or platelet counts, so any unusual symptoms should be reported immediately. There may be signs of liver problems or jaundice, so attention to liver health is necessary. Gastrointestinal symptoms such as gastritis, vomiting, and abdominal pain may occur, so if symptoms persist, consult a physician. While taking this medication, adequate hydration should be maintained to prevent dehydration and reduce strain on the kidneys. This medication is most effective when taken as soon as symptoms begin; if symptoms do not improve during the treatment period, consult a physician. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication, and those who are nursing should avoid taking it or stop breastfeeding. This medication may interact with other drugs, so inform your physician or pharmacist about any other medications you are taking. In case of overdose, kidney damage or serious neurological symptoms may occur, so seek immediate medical attention for appropriate treatment. While using this medication, it is recommended to avoid driving or operating hazardous machinery, especially for patients with reduced kidney function.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • respiratory distress
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 118 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • Steven-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • attention deficit
  • aggressive behavior
  • depersonalization
  • agitation
  • akinesia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • seizures
  • drowsiness
  • tremors
  • excitation
  • forgetfulness
  • insomnia
  • anxiety
  • talking to oneself
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukocytoclastic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • general malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glucosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disturbances
  • hair loss
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • agitation
  • coma
  • seizures
  • somnolence
  • confusion
  • hallucinations
  • excitation
  • epileptic seizures
  • state of coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain a storage temperature between 1 and 30 degrees Celsius to keep the medication effective for a longer period.

Appearance and packaging

Appearance

Light blue, round tablet

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.